AUB ScholarWorks

Reanalysis of TransVax immunogenicity

Show simple item record

dc.contributor.author Kharfan-Dabaja M.A.
dc.contributor.author Boeckh M.
dc.contributor.author Wilck M.B.
dc.contributor.author Langston A.A.
dc.contributor.author Chu A.H.
dc.contributor.author Wloch M.K.
dc.contributor.author Smith L.R.
dc.contributor.author Rolland A.P.
dc.contributor.author Kenney R.T.
dc.contributor.editor
dc.date 2013
dc.date.accessioned 2017-10-05T15:38:25Z
dc.date.available 2017-10-05T15:38:25Z
dc.date.issued 2013
dc.identifier 10.1016/S1473-3099(12)70296-7
dc.identifier.isbn
dc.identifier.issn 14733099
dc.identifier.uri http://hdl.handle.net/10938/16322
dc.description.abstract [No abstract available]
dc.format.extent
dc.language English
dc.publisher NEW YORK
dc.relation.ispartof Publication Name: The Lancet Infectious Diseases; Publication Year: 2013; Volume: 13; no. 1; Pages: (18
dc.relation.ispartofseries
dc.relation.uri
dc.source Scopus
dc.subject.other
dc.title Reanalysis of TransVax immunogenicity
dc.type Letter
dc.contributor.affiliation Kharfan-Dabaja, M.A., Department of Blood and Marrow Transplantation, H Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL, United States, Department of Oncological Sciences, H Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL, United States, American University of Beirut Medical Center, Division of Hematology-Oncology and Bone Marrow Transplantation, Beirut, Lebanon
dc.contributor.affiliation Boeckh, M., Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States
dc.contributor.affiliation Wilck, M.B., Division of Infectious Diseases, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston MA, United States, Division of Infectious Diseases, Hospital of the University of Pennsylvania, Philadelphia, PA, United States
dc.contributor.affiliation Langston, A.A., Bone Marrow and Stem Cell Transplant Center, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, United States
dc.contributor.affiliation Chu, A.H., Department of Clinical Development, Vical, San Diego, CA, United States
dc.contributor.affiliation Wloch, M.K., Department of Vaccinology, Vical, San Diego, CA, United States
dc.contributor.affiliation Smith, L.R., Department of Vaccinology, Vical, San Diego, CA, United States
dc.contributor.affiliation Rolland, A.P., Department of Product Development, Vical, San Diego, CA, United States
dc.contributor.affiliation Kenney, R.T., Crucell Holland BV, Leiden, Netherlands
dc.contributor.authorAddress Kharfan-Dabaja, M.A.; Department of Blood and Marrow Transplantation, H Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL, United States
dc.contributor.authorCorporate University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Internal Medicine; Division: Hematology-Oncology;
dc.contributor.authorDepartment Internal Medicine
dc.contributor.authorDivision Hematology-Oncology
dc.contributor.authorEmail
dc.contributor.authorFaculty Faculty of Medicine
dc.contributor.authorInitials Kharfan-Dabaja, MA
dc.contributor.authorInitials Boeckh, M
dc.contributor.authorInitials Wilck, MB
dc.contributor.authorInitials Langston, AA
dc.contributor.authorInitials Chu, AH
dc.contributor.authorInitials Wloch, MK
dc.contributor.authorInitials Smith, LR
dc.contributor.authorInitials Rolland, AP
dc.contributor.authorInitials Kenney, RT
dc.contributor.authorOrcidID
dc.contributor.authorReprintAddress Kharfan-Dabaja, MA (reprint author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr and Res Inst, Dept Blood and Marrow Transplantat, Tampa, FL 33612 USA.
dc.contributor.authorResearcherID
dc.contributor.authorUniversity American University of Beirut Medical Center
dc.description.cited Kharfan-Dabaja MA, 2012, LANCET INFECT DIS, V12, P290, DOI 10.1016-S1473-3099(11)70344-9
dc.description.citedCount 1
dc.description.citedTotWOSCount 2
dc.description.citedWOSCount 2
dc.format.extentCount -17
dc.identifier.articleNo
dc.identifier.coden LIDAB
dc.identifier.pubmedID 23257230
dc.identifier.scopusID 84871039765
dc.identifier.url
dc.publisher.address 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
dc.relation.ispartofConference
dc.relation.ispartofConferenceCode
dc.relation.ispartofConferenceDate
dc.relation.ispartofConferenceHosting
dc.relation.ispartofConferenceLoc
dc.relation.ispartofConferenceSponsor
dc.relation.ispartofConferenceTitle
dc.relation.ispartofFundingAgency
dc.relation.ispartOfISOAbbr Lancet Infect. Dis.
dc.relation.ispartOfIssue 1
dc.relation.ispartOfPart
dc.relation.ispartofPubTitle The Lancet Infectious Diseases
dc.relation.ispartofPubTitleAbbr Lancet Infect. Dis.
dc.relation.ispartOfSpecialIssue
dc.relation.ispartOfSuppl
dc.relation.ispartOfVolume 13
dc.source.ID WOS:000312762100019
dc.type.publication Journal
dc.subject.otherAuthKeyword
dc.subject.otherChemCAS Vaccines, DNA
dc.subject.otherChemCAS Viral Vaccines
dc.subject.otherIndex Cytomegalovirus vaccine
dc.subject.otherIndex phosphoprotein
dc.subject.otherIndex phosphoprotein 65
dc.subject.otherIndex unclassified drug
dc.subject.otherIndex allotransplantation
dc.subject.otherIndex enzyme linked immunospot assay
dc.subject.otherIndex hemopoietic stem cell transplantation
dc.subject.otherIndex human
dc.subject.otherIndex immunogenicity
dc.subject.otherIndex letter
dc.subject.otherIndex priority journal
dc.subject.otherIndex stem cell transplantation
dc.subject.otherIndex Antibody Formation
dc.subject.otherIndex Clinical Trials, Phase II as Topic
dc.subject.otherIndex Cytomegalovirus
dc.subject.otherIndex Cytomegalovirus Infections
dc.subject.otherIndex Humans
dc.subject.otherIndex Vaccines, DNA
dc.subject.otherIndex Viral Vaccines
dc.subject.otherKeywordPlus
dc.subject.otherWOS Infectious Diseases


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search AUB ScholarWorks


Browse

My Account